Nearly every American city has a hospital that, from the outside, appears to be a monument to advancement. towers of glass. Rooftop helicopter pads. artwork for lobbying. Nevertheless, year after year, the same patients in those buildings experience the same conditions: diabetes is controlled but never cured, heart failure is stabilized before being readmitted, and obesity is recognized but discreetly disregarded. After a while, it becomes difficult to ignore the pattern. The structure becomes more modern. The illnesses don’t change.
The fundamental paradox of American medicine is this. The United States spends about $4 trillion a year on healthcare, more than any other nation on the planet, but its results fall short of those of countries that spend much less. Nowadays, diabetes, cancer, and cardiovascular disease account for almost 75% of all healthcare spending and nearly 70% of all deaths in the United States. These are neither genetic inevitabilities nor freak accidents. The majority of them can be avoided. The majority of them grow gradually over decades, influenced by circumstances, diet, environment, and behavior. Nevertheless, the system continues to wait to react until a crisis arises.
The phrase “sick care” has become more common in both medical literature and congressional hearings, and it accurately describes the real source of funding. Over the past century, reimbursement systems have been developed that favor procedures over discussions, specialists over primary care physicians, and surgery over long-term lifestyle interventions. A family doctor who spends months advising a patient on dietary modifications that could have completely avoided the blockage makes less money in an afternoon than a cardiologist who places a stent. That’s economics, not cynicism. Additionally, those economists have created a system that is structurally more effective at treating disease than preventing it.
It makes perfect sense to move toward what researchers and policy advocates refer to as “whole health”—a model focused on prevention, upstream social factors, mental well-being, and true patient involvement. It’s possible that the majority of doctors already support it, at least in theory. For years, the Veterans Affairs system has been covertly developing a model similar to this one, combining clinical care with social interaction, financial stability, and stable housing, with quantifiable outcomes. There is a framework. The evidence is mounting.
A financial framework that is prepared to support it on a large scale is still lacking. Patenting prevention is infamously challenging. A community walking program, a vegetable garden in a food desert, or a behavioral counseling program—none of these produce the kind of return that draws venture capital or maintains a hospital’s quarterly margins. It seems that in order for whole health to become the norm rather than the exception, the entire financial structure of American medicine would need to be renegotiated.
Many powerful people are at risk from that renegotiation. Private equity-backed hospital systems, insurance behemoths, and pharmaceutical companies have all spent decades creating revenue models centered on treating chronic illness rather than eradicating it. There is more to the transition than just a medical issue. It’s a financial crisis disguised in terms of public health.
As this develops, it becomes evident that ignorance is not the cause of the resistance. The majority of system users are aware of the issue. A century of institutional identity, infrastructure, and incentives centered on the acute care model is the source of the resistance. A Senate hearing or a single policy won’t change that. It will necessitate a more thorough cultural understanding of the true purpose of medicine, which is to help people prevent illness rather than treat it indefinitely. To be honest, it’s still unclear if the money will ever follow that ambition.
